|
GGNBP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.394800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.223100E-03 |
| Normal-vs-Stage2 |
7.784200E-03 |
| Normal-vs-Stage3 |
2.441100E-03 |
| Normal-vs-Stage4 |
1.922640E-03 |
| Stage1-vs-Stage2 |
3.300000E-01 |
| Stage1-vs-Stage3 |
3.199400E-01 |
| Stage1-vs-Stage4 |
3.001600E-01 |
| Stage2-vs-Stage3 |
8.166200E-01 |
| Stage2-vs-Stage4 |
8.920400E-01 |
| Stage3-vs-Stage4 |
9.237200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.022200E-03 |
| Normal-vs-AfricanAmerican |
4.349200E-01 |
| Normal-vs-Asian |
8.670100E-02 |
| Caucasian-vs-AfricanAmerican |
1.965760E-01 |
| Caucasian-vs-Asian |
4.330400E-01 |
| AfricanAmerican-vs-Asian |
5.403200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.943300E-03 |
| Normal-vs-Female |
1.095830E-03 |
| Male-vs-Female |
9.471400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.046280E-02 |
| Normal-vs-Age(41-60Yrs) |
1.496230E-03 |
| Normal-vs-Age(61-80Yrs) |
6.372100E-04 |
| Normal-vs-Age(81-100Yrs) |
8.400000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.489200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.722830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.037000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.862200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.133200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.879000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.944000E-02 |
| Classical-VS-Follicular |
2.068300E-02 |
| Classical-VS-Other |
3.768400E-01 |
| Classical-VS-Normal |
4.459800E-02 |
| Tall-VS-Follicular |
9.084600E-01 |
| Tall-VS-Other |
9.887200E-01 |
| Tall-VS-Normal |
3.236700E-03 |
| Follicular-VS-Other |
9.519000E-01 |
| Follicular-VS-Normal |
8.425000E-04 |
| Other-VS-Normal |
9.658300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.582850E-04 |
| Normal-vs-N1 |
8.577000E-03 |
| N0-vs-N1 |
8.413200E-01 |
|
|
